Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
Galectins are small proteins with pleiotropic functions, which depend on both their lectin (glycan recognition) and non-lectin (recognition of other biomolecules besides glycans) interactions. Currently, 15 members of this family have been described in mammals, each with its structural and ligand re...
Main Authors: | Daniel Compagno, Carolina Tiraboschi, José Daniel Garcia, Yorfer Rondón, Enrique Corapi, Carla Velazquez, Diego José Laderach |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/5/750 |
Similar Items
-
Inhibition of galectins in cancer: Biological challenges for their clinical application
by: Diego José Laderach, et al.
Published: (2023-01-01) -
Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives
by: Efstathia Pasmatzi, et al.
Published: (2019-07-01) -
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
by: Diego José Laderach, et al.
Published: (2021-09-01) -
Role of Galectins in Multiple Myeloma
by: Paola Storti, et al.
Published: (2017-12-01) -
A Synthetic Tetramer of Galectin-1 and Galectin-3 Amplifies Pro-apoptotic Signaling by Integrating the Activity of Both Galectins
by: Shaheen A. Farhadi, et al.
Published: (2020-01-01)